S100A9 and pulmonary arterial hypertension: S100a9 deletion alleviated the pulmonary arterial remodeling and right ventricular dysfunction in PAH mice.<h4>Conclusion</h4>In conclusion, this study established a comprehensive transcriptome and chromatin accessibility atlas for PAH mice and further indicated that activation of S100a9-expressing inflammatory cell might be associated with the development of PAH.